These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626 [TBL] [Abstract][Full Text] [Related]
52. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses. Wang Z; Kedzierski L; Nuessing S; Chua BYL; Quiñones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers. Krairittichai U; Chittaganpitch M J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S1-7. PubMed ID: 23682516 [TBL] [Abstract][Full Text] [Related]
54. Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial. Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Abitay R; Nurpeisova A; Sagymbay A; Koshemetov Z; Stukova M; Buzitskaya Z; Кulmagambetov I; Karabayeva D; Davlyatshin T; Khairullin B J Med Virol; 2018 Jan; 90(1):41-49. PubMed ID: 28842994 [TBL] [Abstract][Full Text] [Related]
55. Pre-exposure with influenza A virus A/WSN/1933(H1N1) resulted in viral shedding reduction from pigs challenged with either swine H1N1 or H3N2 virus. Wang Z; Yu J; Thomas M; Sreenivasan CC; Hause BM; Wang D; Francis DH; Kaushik RS; Li F Vet Microbiol; 2019 Jan; 228():26-31. PubMed ID: 30593376 [TBL] [Abstract][Full Text] [Related]
56. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
57. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779 [TBL] [Abstract][Full Text] [Related]
58. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F; Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723 [TBL] [Abstract][Full Text] [Related]
59. Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies. Hauge S; Madhun A; Cox RJ; Haaheim LR Clin Vaccine Immunol; 2007 Aug; 14(8):978-83. PubMed ID: 17596426 [TBL] [Abstract][Full Text] [Related]